MIRA Pharmaceuticals, Inc. (MIRA)
0.7054
-0.04
(-5.38%)
USD |
NASDAQ |
Oct 12, 16:00
0.707
0.00 (0.00%)
After-Hours: 06:51
MIRA Pharmaceuticals Enterprise Value : 21.53M for Oct. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 21.53M |
| October 09, 2026 | 23.21M |
| October 08, 2026 | 21.43M |
| October 07, 2026 | 21.72M |
| October 06, 2026 | 21.80M |
| October 05, 2026 | 22.79M |
| October 02, 2026 | 22.57M |
| October 01, 2026 | 22.27M |
| September 30, 2026 | 27.39M |
| September 29, 2026 | 28.51M |
| September 28, 2026 | 29.85M |
| September 25, 2026 | 29.71M |
| September 24, 2026 | 27.16M |
| September 23, 2026 | 27.93M |
| September 22, 2026 | 29.96M |
| September 21, 2026 | 28.82M |
| September 18, 2026 | 26.86M |
| September 17, 2026 | 23.79M |
| September 16, 2026 | 22.13M |
| September 15, 2026 | 21.89M |
| September 14, 2026 | 23.51M |
| September 11, 2026 | 24.40M |
| September 10, 2026 | 25.05M |
| September 09, 2026 | 24.68M |
| September 08, 2026 | 24.49M |
| Date | Value |
|---|---|
| September 04, 2026 | 23.98M |
| September 03, 2026 | 22.97M |
| September 02, 2026 | 27.58M |
| September 01, 2026 | 28.03M |
| August 31, 2026 | 24.25M |
| August 28, 2026 | 23.41M |
| August 27, 2026 | 24.25M |
| August 26, 2026 | 23.40M |
| August 25, 2026 | 24.47M |
| August 24, 2026 | 25.00M |
| August 21, 2026 | 23.97M |
| August 20, 2026 | 21.73M |
| August 19, 2026 | 24.25M |
| August 18, 2026 | 24.01M |
| August 17, 2026 | 25.08M |
| August 14, 2026 | 24.67M |
| August 13, 2026 | 23.41M |
| August 12, 2026 | 22.93M |
| August 11, 2026 | 24.57M |
| August 10, 2026 | 24.13M |
| August 07, 2026 | 22.98M |
| August 06, 2026 | 20.39M |
| August 05, 2026 | 19.52M |
| August 04, 2026 | 20.25M |
| August 03, 2026 | 17.68M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Resonate Blends, Inc. | 5.808M |
| Breakthrough Chemistry, Inc. | 0.0562M |
| Kaya Holdings, Inc. | -- |
| Cardiac Biotech Solutions, Inc. | 6.491M |
| Endexx Corp. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.208M |
| Total Expenses (Quarterly) | 1.208M |
| EPS Diluted (Quarterly) | -0.0288 |
| Earnings Yield | -195.1% |
| Normalized Earnings Yield | -195.08 |